Diltiazem and exercise performance in patients with chronic atrial fibrillation. 1988

J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
Cardiology Section, Veterans Administration Medical Center, Long Beach, CA 90822.

To evaluate the influence of calcium entry blockade (diltiazem 60 mg qid) on exercise capacity in patients with chronic atrial fibrillation, nine men (mean age 65 years) with atrial fibrillation underwent maximal treadmill exercise on and off diltiazem therapy. Heart rate, blood pressure, and measured ventilatory parameters were assessed at a standard submaximal workload (3.0 mph/0% grade), the gas exchange anaerobic threshold (ATge), and maximal exercise. Significant reductions in heart rate at all stages of exercise were demonstrated: maximum heart rate decreased from 171 +/- 30 beats/min to 142 +/- 27 beats/min (17 percent, p less than .01) and submaximal exercise heart rate decreased from 123 +/- 22 beats/min to 96 +/- 16 beats/min (22 percent, p less than .01). However, there were no significant changes in blood pressure or gas exchange data, ie, oxygen uptake, minute ventilation, or respiratory exchange ratio at any of the exercise workloads. These data demonstrate that in patients with chronic atrial fibrillation, diltiazem controls the ventricular rate response throughout exercise without attenuating blood pressure or exercise capacity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004110 Diltiazem A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. Aldizem,CRD-401,Cardil,Cardizem,Dilacor,Dilacor XR,Dilren,Diltiazem Hydrochloride,Diltiazem Malate,Dilzem,Tiazac,CRD 401,CRD401
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
July 1990, Journal of the American College of Cardiology,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
April 1985, Journal of clinical pharmacology,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
November 1992, The Journal of the Association of Physicians of India,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
January 2000, Journal of cardiopulmonary rehabilitation,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
January 1996, Journal of cardiopulmonary rehabilitation,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
January 2006, Journal of cardiopulmonary rehabilitation,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
January 1995, Cardiology,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
June 2021, BMC cardiovascular disorders,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
March 2007, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
J E Atwood, and J N Myers, and M J Sullivan, and S M Forbes, and W F Pewen, and V F Froelicher
April 2017, Journal of the American College of Cardiology,
Copied contents to your clipboard!